BioMed Research International

Acute Leukemia in Children


Status
Published

1Mexican Institute of the Social Security and Coordination of the Research in Health, Mexico, Mexico

2Institute of Health & Society, Newcastle upon Tyne, UK


Acute Leukemia in Children

Description

Acute leukemias (AL) are the most common cancers during the first 15 years of age. At the last 20 years, the survival has been increased in developed countries, and however mortality is higher in developing countries and inclusive in many, in developing countries, the survival for AL is unknown due to the lack of good data. Improvement in survival probably should be first priority. We still do not understand etiology–hypothesize about infections and other causes; the possibility of the prevention of AL in this moment is only a good dream. It is possible that the way we are following is incorrect and that we need to change the methods, design, and hypothesis to identify the causes of the AL.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the etiology of AL and the development of strategies to prevent the AL in children, such as protocols of treatment of AL in children in the developing countries.

Potential topics include, but are not limited to:

  • Dimension of the problem in developing countries (incidence and survival)
  • Data on the incidence, trend, and survival in the whole World
  • New methods and the identification of new risk factors (both genetic and environmental) in the causality of AL in the whole world
  • The implementation of biomarkers for assessing the prognostic of the children with AL
  • New hypothesis and meta-analysis on the etiology of AL in children

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 787194
  • - Editorial

Acute Leukemia in Children

Juan Manuel Mejía-Aranguré | Richard J. Q. McNally
  • Special Issue
  • - Volume 2015
  • - Article ID 386165
  • - Research Article

Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates

Armando Vilchis-Ordoñez | Adriana Contreras-Quiroz | ... | Rosana Pelayo
  • Special Issue
  • - Volume 2015
  • - Article ID 732495
  • - Research Article

Maternal Alcohol Consumption during Pregnancy and Early Age Leukemia Risk in Brazil

Jeniffer Dantas Ferreira | Arnaldo Cézar Couto | ... | Sergio Koifman
  • Special Issue
  • - Volume 2015
  • - Article ID 309491
  • - Clinical Study

Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia

Aurora Medina-Sanson | Arturo Ramírez-Pacheco | ... | Alfonso Reyes-López
  • Special Issue
  • - Volume 2014
  • - Article ID 548097
  • - Research Article

EBV, HCMV, HHV6, and HHV7 Screening in Bone Marrow Samples from Children with Acute Lymphoblastic Leukemia

A. Morales-Sánchez | E. N. Pompa-Mera | ... | E. M. Fuentes-Pananá
  • Special Issue
  • - Volume 2014
  • - Article ID 945860
  • - Research Article

Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukemia

Małgorzata Czogała | Walentyna Balwierz | ... | Iwona Rogatko
  • Special Issue
  • - Volume 2014
  • - Article ID 210560
  • - Research Article

Prevalence of Gene Rearrangements in Mexican Children with Acute Lymphoblastic Leukemia: A Population Study—Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia

Vilma Carolina Bekker-Méndez | Enrique Miranda-Peralta | ... | Juan Manuel Mejía-Aranguré
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.